Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia

Published:2017-08 Issue:8 Volume:25 Page:1933-1945
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Arcangeli Silvia,Rotiroti Maria Caterina,Bardelli Marco,Simonelli Luca,Magnani Chiara Francesca,Biondi Andrea,Biagi Ettore,Tettamanti Sarah,Varani Luca

Funder

AIRC

Fondazione Just Italia

SNF

Oncosuisse

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference35 articles.

1. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells;Gill;Blood,2014

2. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias;Brentjens;Blood,2011

3. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

4. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

5. Current and emerging therapies for acute myeloid leukemia;Robak;Clin. Ther.,2009

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The peptide-based bispecific CAR T cells target EGFR and tumor stroma for effective cancer therapy;International Journal of Pharmaceutics;2024-09

2. CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects;Frontiers in Immunology;2024-07-18

3. Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization;Frontiers in Immunology;2024-04-19

4. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects;Molecular Cancer;2024-03-16

5. Recent advances in CAR-T therapy for the treatment of acute myeloid leukemia;Therapeutic Advances in Hematology;2024-01